Hospira, Inc. specializes in the development, manufacture, and distribution of injectable drugs and infusion technologies on a global scale. The company offers a diverse range of specialty injectable pharmaceuticals, including approximately 200 generic injectable drugs and proprietary products such as Precedex for sedation. Its portfolio also features biosimilars like Retacrit, Nivestim, and Inflectra, aimed at treating various medical conditions, including anemia and autoimmune diseases. Additionally, Hospira provides medication management products, including infusion pumps and safety software systems, designed to enhance patient and caregiver safety. The company serves a wide array of healthcare settings, including hospitals, clinics, home healthcare providers, and long-term care facilities. Founded in 2003 and headquartered in Lake Forest, Illinois, Hospira operates as a subsidiary of Pfizer Inc., leveraging collaborations with other entities to expand its market reach and product offerings.
BresaGen is a developer of proteins and peptides, especially biogenerics. In October 2006, BresaGen was sold to Hospira Inc of the US, and Paragon made a 2.35x return on investment, and 135% IRR. Hospira acquired the company to further develop BresaGen’s intellectual property, and to distribute its products in the US.
Physiometrix
Acquisition in 2005
Physiometrix is a medical device firm that manufactures non-invasive medical products for use in anesthesia. The company was founded in 1990 and is headquartered in Billerica, Massachusetts, United States.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.